Dynatronics Stock News

EAGAN, MN / ACCESSWIRE / September 8, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the

Dynatronics Corporation (NASDAQ:DYNT ) Q3 2022 Earnings Conference Call May 12, 2022 10:00 AM ET Company Participants Norm Roegner – Chief Financial Officer John Krier – President and Chief Execut

EAGAN, MN / ACCESSWIRE / April 28, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the co

Roth Capital: March 14, 2022 Maxim Group: March 28-29, 2022 EAGAN, MN / ACCESSWIRE / March 2, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therap

Dynatronics Corporation (DYNT) CEO John Krier on Q2 2022 Results - Earnings Call Transcript

Dynatronics press release (DYNT): FQ2 GAAP EPS of -$0.09.Revenue of $10.53M (-12.0% Y/Y).The company expects net sales in FY 22 to be $40M to $45M, assuming similar procedure…

EAGAN, MN / ACCESSWIRE / January 27, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the

Dynatronics Corp. (DYNT) shares closed today at 2.0% above its 52 week low of $0.93, giving the company a market cap of $16M. The stock is currently down 4.9% year-to-date, down 7.7% over the past 12 months, and down 59.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 61.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -0.4% The company's stock price performance over the past 12 months lags the peer average by 2786.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -28.6% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Dynatronics Corp. (DYNT) shares closed today at 2.0% above its 52 week low of $0.93, giving the company a market cap of $16M. The stock is currently down 4.9% year-to-date, down 5.9% over the past 12 months, and down 59.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 61.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.6% lower than its 5-day moving average, 6.1% lower than its 20-day moving average, and 26.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 4.3% The company's stock price performance over the past 12 months lags the peer average by -1562.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -29.4% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zacks Investment Research cut shares of Dynatronics (NASDAQ:DYNT) from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. DYNT has been the topic of several other []

Zacks Investment Research upgraded shares of Dynatronics (NASDAQ:DYNT) from a hold rating to a buy rating in a research note published on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $1.25 price objective on the medical equipment providers stock. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical []

Zacks Investment Research downgraded shares of Dynatronics (NASDAQ:DYNT) from a buy rating to a hold rating in a research note released on Monday, Zacks.com reports. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. A number of other equities analysts have []

Zacks Investment Research upgraded shares of Dynatronics (NASDAQ:DYNT) from a hold rating to a buy rating in a research report released on Wednesday morning, Zacks.com reports. Zacks Investment Research currently has $1.25 price objective on the medical equipment providers stock. According to Zacks, DYNATRONICS CORP. is involved in the design, manufacture and sale of medical []